We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Healthcare Trust of America Inc New | NYSE:HTA | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.19 | 0 | 01:00:00 |
SCOTTSDALE, Ariz., Oct. 24, 2017 /PRNewswire/ -- Healthcare Trust of America, Inc. (NYSE: HTA) ("HTA") announced results for the three and nine months ended September 30, 2017.
Third Quarter 2017 Highlights
Operating
Portfolio
2017 Investments - Q3 Performance
Capital Markets
Year-to-Date 2017 Highlights
Operating
Portfolio
Balance Sheet and Capital Markets
Subsequent Events
Financial Results - Third Quarter 2017
Rental Income
Rental income increased 48.4% to $175.4 million for the three months ended September 30, 2017, compared to $118.3 million for the three months ended September 30, 2016.
Net Income
Net income increased 110.2% to $14.0 million for the three months ended September 30, 2017, compared to $6.6 million net income for the three months ended September 30, 2016.
FFO
FFO, as defined by NAREIT, was $0.41 per diluted share, or $84.2 million, for the three months ended September 30, 2017, compared to $0.38 per diluted share, or $54.0 million, for the three months ended September 30, 2016.
Normalized FFO
Normalized FFO was $0.42 per diluted share, or $85.4 million, for the three months ended September 30, 2017, compared to $0.40 per diluted share, or $57.1 million, for the three months ended September 30, 2016.
Normalized FAD
Normalized FAD increased 51.9% to $74.8 million, for the three months ended September 30, 2017, compared to $49.2 million for the three months ended September 30, 2016.
NOI
NOI increased 46.9% to $119.7 million for the three months ended September 30, 2017, compared to $81.5 million for the three months ended September 30, 2016.
Same-Property Cash NOI
Same-Property Cash NOI increased $2.2 million, or 2.9%, to $80.3 million, for the three months ended September 30, 2017, compared to $78.0 million for the three months ended September 30, 2016.
General and Administrative Expenses
General and administrative expenses were $8.3 million for the three months ended September 30, 2017, compared to $7.3 million for the three months ended September 30, 2016.
Interest Expense and Change in Fair Value of Derivative Financial Instruments
The total interest expense and change in fair value of derivative financial instruments for the three months ended September 30, 2017, was $26.2 million, all of which related to debt and interest rate swaps.
Investment Activity
During the three months ended September 30, 2017, HTA completed investments of $160.7 million, totaling approximately 314,000 square feet of GLA which were 99% leased as of the acquisition date.
Tenant Retention
Tenant retention for the Same-Property portfolio was 75% by GLA for the quarter, which included approximately 289,000 square feet of GLA of expiring leases.
Financial Results - Year-to-Date 2017
Rental Income
Rental income increased 29.6% to $438.9 million for the nine months ended September 30, 2017, compared to $338.6 million for the nine months ended September 30, 2016.
Net Income
Net income decreased 26.8% to $22.1 million for the nine months ended September 30, 2017, compared to $30.2 million for the nine months ended September 30, 2016. Total revenues increased $101.3 million due to the continued growth in HTA's operations, however, the increase in revenues was primarily offset as a result of the Duke acquisition by the increase in transaction expenses and loss on extinguishment of debt related to bridge facility fees paid.
FFO
FFO, as defined by NAREIT, was $1.12 per diluted share, or $198.7 million, for the nine months ended September 30, 2017, compared to $1.12 per diluted share, or $154.6 million, for the nine months ended September 30, 2016.
Normalized FFO
Normalized FFO was $1.21 per diluted share, or $215.2 million, for the nine months ended September 30, 2017, compared to $1.20 per diluted share, or $165.7 million, for the nine months ended September 30, 2016.
Normalized FAD
Normalized FAD increased 27.3% to $188.3 million, for the nine months ended September 30, 2017, compared to $147.9 million for the nine months ended September 30, 2016.
NOI
NOI increased 29.0% to $301.3 million for the nine months ended September 30, 2017, compared to $233.6 million for the nine months ended September 30, 2016.
Same-Property Cash NOI
Same-Property Cash NOI increased $6.6 million, or 3.1%, to $217.8 million, for the nine months ended September 30, 2017, compared to $211.1 million for the nine months ended September 30, 2016. Same-Property rental revenue increased $4.1 million, or 1.7%, to $243.4 million, for the nine months ended September 30, 2017, compared to the nine months ended September 30, 2016.
General and Administrative Expenses
General and administrative expenses were $25.2 million for the nine months ended September 30, 2017, compared to $20.9 million for the nine months ended September 30, 2016.
Interest Expense and Change in Fair Value of Derivative Financial Instruments
The total interest expense and change in fair value of derivative financial instruments for the nine months ended September 30, 2017, was $59.6 million, which included $60.5 million of interest expense related to debt and interest rate swaps, and a net gain of $0.9 million on the change in the fair value of HTA's derivative financial instruments.
HTA ended the quarter with a weighted average interest rate of 3.44% per annum, including the impact of interest rate swaps. The weighted average remaining term of HTA's total debt was 5.9 years, including extension options.
Investment Activity
During the nine months ended September 30, 2017, HTA completed investments of $2.7 billion, net of development credits received at the closing of the Duke acquisition, including its investment in a unconsolidated joint venture, totaling 6.6 million square feet of GLA, including projects under development, which were 92% leased as of the acquisition date.
Leased Rate, Occupancy Rate and Tenant Retention
The leased rate (includes leases which have been executed, but which have not yet commenced) was 91.7% by GLA as of September 30, 2017. The occupancy rate of HTA's portfolio was 90.6% by GLA as of September 30, 2017. Tenant retention for the Same-Property portfolio was 78% by GLA year-to-date, which included approximately 1.3 million square feet of GLA of expiring leases.
Credit Rated Tenants
Investment grade rated tenants as a percent of annualized base rent was 47% as of September 30, 2017. Additionally, 61% of HTA's annualized base rent as of September 30, 2017 was derived from tenants that have (or whose parent companies have) a credit rating from a nationally recognized rating agency.
In-House Property Management and Leasing Platform
As of September 30, 2017, HTA's in-house property management and leasing platform operated approximately 22.2 million square feet of GLA, or 92%, of HTA's total portfolio.
Balance Sheet
As of September 30, 2017, HTA had total assets of $6.4 billion, cash and cash equivalents of $9.4 million, and $919.5 million available under its unsecured revolving credit facility (includes the impact of $5.5 million of outstanding letters of credit). The leverage ratio of debt to total capitalization was 31.9% as of September 30, 2017.
About Healthcare Trust of America, Inc.
Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings ("MOBs") in the United States based on gross leasable area ("GLA"). We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations. Over the last decade, we have invested $7.0 billion primarily in MOBs and other healthcare assets comprising 24.2 million square feet of GLA. Our investments are targeted in 20 to 25 key markets that we believe have superior healthcare demographics that support strong, long-term demand for medical office space. We have achieved, and continue to achieve, critical mass within these key markets by expanding our presence through accretive acquisitions, and utilizing our in-house operating expertise through our regionally located property management and leasing platform.
Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that we believe have significantly outperformed the S&P 500 and US REIT indices. More information about HTA can be found on the Company's website at www.htareit.com.
Forward-Looking Language
This press release contains certain forward-looking statements with respect to HTA. Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements. These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K and in our filings with the SEC.
Conference Call
HTA will host a conference call and webcast on Wednesday, October 25, 2017 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time) to review its financial performance and operating results for the three and nine months ended September 30, 2017.
Conference Call and Webcast Details:
Domestic Dial-In Number: (877) 507-6265
International Dial-In Number: (412) 902-6633
Canada Dial-In Number: (855) 669-9657
Webcast: www.htareit.com under the Investor Relations tab
Replay Conference Call Details:
Domestic Dial-In Number: (877) 344-7529
International Dial-In Number: (412) 317-0088
Canada Dial-In Number: (855) 669-9658
Conference ID: 10112394
Available October 25, 2017 (one hour after the end of the conference call) to November 1, 2017 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time)
Supplemental Information
Supplemental financial data are available on the HTA's website at www.htareit.com.
Financial Contact:
Robert A. Milligan
Chief Financial Officer
480.998.3478
HEALTHCARE TRUST OF AMERICA, INC. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
(In thousands, except share data) | ||||||||
(Unaudited) | ||||||||
September 30, 2017 |
December 31, 2016 | |||||||
ASSETS |
||||||||
Real estate investments: |
||||||||
Land |
$ |
480,850 |
$ |
386,526 |
||||
Building and improvements |
5,788,837 |
3,466,516 |
||||||
Lease intangibles |
648,591 |
467,571 |
||||||
Construction in progress |
59,573 |
— |
||||||
6,977,851 |
4,320,613 |
|||||||
Accumulated depreciation and amortization |
(973,566) |
(817,593) |
||||||
Real estate investments, net |
6,004,285 |
3,503,020 |
||||||
Investment in unconsolidated joint venture |
68,303 |
— |
||||||
Cash and cash equivalents |
9,410 |
11,231 |
||||||
Restricted cash and escrow deposits |
17,469 |
13,814 |
||||||
Receivables and other assets, net |
206,030 |
173,461 |
||||||
Other intangibles, net |
108,025 |
46,318 |
||||||
Total assets |
$ |
6,413,522 |
$ |
3,747,844 |
||||
LIABILITIES AND EQUITY |
||||||||
Liabilities: |
||||||||
Debt |
$ |
2,856,758 |
$ |
1,768,905 |
||||
Accounts payable and accrued liabilities |
159,070 |
105,034 |
||||||
Derivative financial instruments - interest rate swaps |
1,441 |
1,920 |
||||||
Security deposits, prepaid rent and other liabilities |
61,402 |
49,859 |
||||||
Intangible liabilities, net |
69,852 |
37,056 |
||||||
Total liabilities |
3,148,523 |
1,962,774 |
||||||
Commitments and contingencies |
||||||||
Redeemable noncontrolling interests |
4,692 |
4,653 |
||||||
Equity: |
||||||||
Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding |
— |
— |
||||||
Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 200,686,673 and 141,719,134 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively |
2,007 |
1,417 |
||||||
Additional paid-in capital |
4,386,224 |
2,754,818 |
||||||
Accumulated other comprehensive loss |
(615) |
— |
||||||
Cumulative dividends in excess of earnings |
(1,212,051) |
(1,068,961) |
||||||
Total stockholders' equity |
3,175,565 |
1,687,274 |
||||||
Noncontrolling interests |
84,742 |
93,143 |
||||||
Total equity |
3,260,307 |
1,780,417 |
||||||
Total liabilities and equity |
$ |
6,413,522 |
$ |
3,747,844 |
HEALTHCARE TRUST OF AMERICA, INC. | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, | ||||||||||||||
2017 |
2016 |
2017 |
2016 | ||||||||||||
Revenues: |
|||||||||||||||
Rental income |
$ |
175,431 |
$ |
118,252 |
$ |
438,949 |
$ |
338,646 |
|||||||
Interest and other operating income |
563 |
88 |
1,271 |
243 |
|||||||||||
Total revenues |
175,994 |
118,340 |
440,220 |
338,889 |
|||||||||||
Expenses: |
|||||||||||||||
Rental |
56,331 |
36,885 |
138,874 |
105,299 |
|||||||||||
General and administrative |
8,283 |
7,293 |
25,178 |
20,879 |
|||||||||||
Transaction |
261 |
1,122 |
5,618 |
4,997 |
|||||||||||
Depreciation and amortization |
70,491 |
47,864 |
172,900 |
130,430 |
|||||||||||
Impairment |
— |
— |
5,093 |
— |
|||||||||||
Total expenses |
135,366 |
93,164 |
347,663 |
261,605 |
|||||||||||
Income before other income (expense) |
40,628 |
25,176 |
92,557 |
77,284 |
|||||||||||
Interest expense: |
|||||||||||||||
Interest related to derivative financial instruments |
(264) |
(552) |
(827) |
(1,856) |
|||||||||||
Gain (loss) on change in fair value of derivative financial instruments, net |
— |
1,306 |
884 |
(2,144) |
|||||||||||
Total interest related to derivative financial instruments, including net change in fair value of derivative financial instruments |
(264) |
754 |
57 |
(4,000) |
|||||||||||
Interest related to debt |
(25,924) |
(16,386) |
(59,688) |
(44,503) |
|||||||||||
Gain on sale of real estate, net |
— |
— |
3 |
4,212 |
|||||||||||
Loss on extinguishment of debt, net |
(774) |
(3,000) |
(11,192) |
(3,022) |
|||||||||||
Income from unconsolidated joint venture |
318 |
— |
381 |
— |
|||||||||||
Other (expense) income |
(27) |
95 |
(13) |
220 |
|||||||||||
Net income |
$ |
13,957 |
$ |
6,639 |
$ |
22,105 |
$ |
30,191 |
|||||||
Net income attributable to noncontrolling interests |
(194) |
(212) |
(715) |
(830) |
|||||||||||
Net income attributable to common stockholders |
$ |
13,763 |
$ |
6,427 |
$ |
21,390 |
$ |
29,361 |
|||||||
Earnings per common share - basic: |
|||||||||||||||
Net income attributable to common stockholders |
$ |
0.07 |
$ |
0.05 |
$ |
0.12 |
$ |
0.22 |
|||||||
Earnings per common share - diluted: |
|||||||||||||||
Net income attributable to common stockholders |
$ |
0.07 |
$ |
0.04 |
$ |
0.12 |
$ |
0.21 |
|||||||
Weighted average common shares outstanding: |
|||||||||||||||
Basic |
200,674 |
138,807 |
173,189 |
134,905 |
|||||||||||
Diluted |
204,795 |
143,138 |
177,410 |
138,314 |
|||||||||||
Dividends declared per common share |
$ |
0.305 |
$ |
0.300 |
$ |
0.905 |
$ |
0.890 |
HEALTHCARE TRUST OF AMERICA, INC. | |||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | |||||||
(In thousands) | |||||||
(Unaudited) | |||||||
Nine Months Ended September 30, | |||||||
2017 |
2016 | ||||||
Cash flows from operating activities: |
|||||||
Net income |
$ |
22,105 |
$ |
30,191 |
|||
Adjustments to reconcile net income to net cash provided by operating activities: |
|||||||
Depreciation, amortization and other |
169,057 |
128,728 |
|||||
Share-based compensation expense |
5,493 |
5,136 |
|||||
Bad debt expense |
635 |
508 |
|||||
Impairment |
5,093 |
— |
|||||
Income from unconsolidated joint venture |
(381) |
— |
|||||
Gain on sale of real estate, net |
(3) |
(4,212) |
|||||
Loss on extinguishment of debt, net |
11,192 |
3,022 |
|||||
Change in fair value of derivative financial instruments |
(884) |
2,144 |
|||||
Changes in operating assets and liabilities: |
|||||||
Receivables and other assets, net |
(20,489) |
(14,051) |
|||||
Accounts payable and accrued liabilities |
29,566 |
3,598 |
|||||
Prepaid rent and other liabilities |
7,158 |
(6,807) |
|||||
Net cash provided by operating activities |
228,542 |
148,257 |
|||||
Cash flows from investing activities: |
|||||||
Investments in real estate |
(2,357,570) |
(532,527) |
|||||
Investment in unconsolidated joint venture |
(68,839) |
— |
|||||
Development of real estate |
(19,163) |
— |
|||||
Proceeds from the sale of real estate |
4,746 |
23,368 |
|||||
Capital expenditures |
(42,990) |
(34,064) |
|||||
Restricted cash, escrow deposits and other assets |
(3,655) |
2,143 |
|||||
Net cash used in investing activities |
(2,487,471) |
(541,080) |
|||||
Cash flows from financing activities: |
|||||||
Borrowings on unsecured revolving credit facility |
515,000 |
513,000 |
|||||
Payments on unsecured revolving credit facility |
(528,000) |
(704,000) |
|||||
Proceeds from unsecured senior notes |
900,000 |
347,725 |
|||||
Borrowings on unsecured term loans |
— |
200,000 |
|||||
Payments on unsecured term loans |
— |
(155,000) |
|||||
Payments on secured mortgage loans |
(75,444) |
(98,453) |
|||||
Deferred financing costs |
(16,902) |
(3,039) |
|||||
Debt extinguishment costs |
(10,391) |
— |
|||||
Security deposits |
1,932 |
862 |
|||||
Proceeds from issuance of common stock |
1,624,222 |
418,891 |
|||||
Repurchase and cancellation of common stock |
(3,413) |
(2,425) |
|||||
Dividends paid |
(145,877) |
(116,655) |
|||||
Distributions paid to noncontrolling interest of limited partners |
(4,019) |
(2,724) |
|||||
Redemption of redeemable noncontrolling interest |
— |
(491) |
|||||
Net cash provided by financing activities |
2,257,108 |
397,691 |
|||||
Net change in cash and cash equivalents |
(1,821) |
4,868 |
|||||
Cash and cash equivalents - beginning of period |
11,231 |
13,070 |
|||||
Cash and cash equivalents - end of period |
$ |
9,410 |
$ |
17,938 |
HEALTHCARE TRUST OF AMERICA, INC. | |||||||||||||||
NOI, CASH NOI AND SAME-PROPERTY CASH NOI | |||||||||||||||
(In thousands) | |||||||||||||||
(Unaudited) | |||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, | ||||||||||||||
2017 |
2016 |
2017 |
2016 | ||||||||||||
Net income |
$ |
13,957 |
$ |
6,639 |
$ |
22,105 |
$ |
30,191 |
|||||||
General and administrative expenses |
8,283 |
7,293 |
25,178 |
20,879 |
|||||||||||
Transaction expenses (1) |
261 |
1,122 |
5,618 |
4,997 |
|||||||||||
Depreciation and amortization expense |
70,491 |
47,864 |
172,900 |
130,430 |
|||||||||||
Impairment |
— |
— |
5,093 |
— |
|||||||||||
Interest expense and net change in fair value of derivative financial instruments |
26,188 |
15,632 |
59,631 |
48,503 |
|||||||||||
Gain on sale of real estate, net |
— |
— |
(3) |
(4,212) |
|||||||||||
Loss on extinguishment of debt, net |
774 |
3,000 |
11,192 |
3,022 |
|||||||||||
Income from unconsolidated joint venture |
(318) |
— |
(381) |
— |
|||||||||||
Other expense (income) |
27 |
(95) |
13 |
(220) |
|||||||||||
NOI |
$ |
119,663 |
$ |
81,455 |
$ |
301,346 |
$ |
233,590 |
|||||||
NOI percentage growth |
46.9 |
% |
29.0 |
% |
|||||||||||
NOI |
$ |
119,663 |
$ |
81,455 |
$ |
301,346 |
$ |
233,590 |
|||||||
Straight-line rent adjustments, net |
(3,009) |
(1,161) |
(5,834) |
(3,636) |
|||||||||||
Amortization of (below) and above market leases/leasehold interests, net and lease termination fees |
214 |
3 |
246 |
497 |
|||||||||||
Cash NOI |
$ |
116,868 |
$ |
80,297 |
$ |
295,758 |
$ |
230,451 |
|||||||
Notes receivable interest income |
(503) |
(68) |
(1,089) |
(68) |
|||||||||||
Non Same-Property Cash NOI |
(36,080) |
(2,186) |
(76,911) |
(19,255) |
|||||||||||
Same-Property Cash NOI (2) |
$ |
80,285 |
$ |
78,043 |
$ |
217,758 |
$ |
211,128 |
|||||||
Same-Property Cash NOI percentage growth |
2.9 |
% |
3.1 |
% |
|||||||||||
(1) |
For the three and nine months ended September 30, 2017, transaction costs have been adjusted to reflect the prospective presentation of the early adoption of ASU 2017-01 as of January 1, 2017. For the nine months ended September 30, 2017, transactions costs included $4.6 million of compensation and severance payments to Duke employees pursuant to the Duke purchase agreements in connection with the Duke acquisition. |
(2) |
Same-Property includes 338 and 296 buildings for the three and nine months ended September 30, 2017 and 2016, respectively. |
NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense and net change in fair value of derivative financial instruments; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; (viii) income or loss from unconsolidated joint venture; and (ix) other income or expense. HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties. Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts ("REITs"). However, HTA's use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount. NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. NOI should be reviewed in connection with other GAAP measurements.
Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments and (ii) amortization of below and above market leases/leasehold interests. Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA's revenue performance. HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets. Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs. However, HTA's use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount. Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Cash NOI should be reviewed in connection with other GAAP measurements.
To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned properties referred to as "Same-Property". Same-Property Cash NOI excludes properties which have not been owned and operated by HTA during the entire span of all periods presented, excluding properties intended for disposition in the near term, notes receivable interest income and certain non-routine items. Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of our financial performance. Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.
HEALTHCARE TRUST OF AMERICA, INC. | |||||||||||||||
FFO, NORMALIZED FFO AND NORMALIZED FAD | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
(Unaudited) | |||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, | ||||||||||||||
2017 |
2016 |
2017 |
2016 | ||||||||||||
Net income attributable to common stockholders |
$ |
13,763 |
$ |
6,427 |
$ |
21,390 |
$ |
29,361 |
|||||||
Depreciation and amortization expense related to investments in real estate |
70,021 |
47,545 |
171,678 |
129,477 |
|||||||||||
Gain on sale of real estate, net |
— |
— |
(3) |
(4,212) |
|||||||||||
Impairment |
— |
— |
5,093 |
— |
|||||||||||
Proportionate share of joint venture depreciation, amortization and other adjustments |
464 |
— |
506 |
— |
|||||||||||
FFO attributable to common stockholders |
$ |
84,248 |
$ |
53,972 |
$ |
198,664 |
$ |
154,626 |
|||||||
Transaction expenses (1) |
261 |
1,122 |
975 |
4,997 |
|||||||||||
(Gain) loss on change in fair value of derivative financial instruments, net |
— |
(1,306) |
(884) |
2,144 |
|||||||||||
Loss on extinguishment of debt, net |
774 |
3,000 |
11,192 |
3,022 |
|||||||||||
Noncontrolling income from partnership units included in diluted shares |
166 |
211 |
635 |
802 |
|||||||||||
Other normalizing items, net (2) |
— |
133 |
4,643 |
117 |
|||||||||||
Normalized FFO attributable to common stockholders |
$ |
85,449 |
$ |
57,132 |
$ |
215,225 |
$ |
165,708 |
|||||||
Other expense (income) |
27 |
(95) |
13 |
(220) |
|||||||||||
Non-cash compensation expense |
1,654 |
2,103 |
5,493 |
5,136 |
|||||||||||
Straight-line rent adjustments, net |
(3,009) |
(1,161) |
(5,834) |
(3,636) |
|||||||||||
Amortization of (below) and above market leases/leasehold interests and corporate assets, net |
683 |
323 |
1,467 |
1,476 |
|||||||||||
Deferred revenue - tenant improvement related |
(12) |
7 |
(23) |
— |
|||||||||||
Amortization of deferred financing costs and debt discount/premium, net |
1,290 |
795 |
2,929 |
2,288 |
|||||||||||
Recurring capital expenditures, tenant improvements and leasing commissions |
(11,315) |
(9,882) |
(31,020) |
(22,866) |
|||||||||||
Normalized FAD attributable to common stockholders |
$ |
74,767 |
$ |
49,222 |
$ |
188,250 |
$ |
147,886 |
|||||||
Net income attributable to common stockholders per diluted share |
$ |
0.07 |
$ |
0.04 |
$ |
0.12 |
$ |
0.21 |
|||||||
FFO adjustments per diluted share, net |
0.34 |
0.34 |
1.00 |
0.91 |
|||||||||||
FFO attributable to common stockholders per diluted share |
$ |
0.41 |
$ |
0.38 |
$ |
1.12 |
$ |
1.12 |
|||||||
Normalized FFO adjustments per diluted share, net |
0.01 |
0.02 |
0.09 |
0.08 |
|||||||||||
Normalized FFO attributable to common stockholders per diluted share |
$ |
0.42 |
$ |
0.40 |
$ |
1.21 |
$ |
1.20 |
|||||||
Weighted average diluted common shares outstanding |
204,795 |
143,138 |
177,410 |
138,314 |
|||||||||||
(1) |
For the three and nine months ended September 30, 2017, amounts have been adjusted to reflect the prospective presentation of the early adoption of ASU 2017-01 as of January 1, 2017. |
(2) |
For the nine months ended September 30, 2017, other normalizing items include $4.6 million of compensation and severance payments to Duke employees pursuant to the Duke purchase agreements in connection with the Duke acquisition that were included in transaction expenses on HTA's condensed consolidated statements of operations. In addition, other normalizing items excludes lease termination fees as they are deemed to be generated in the ordinary course of business. |
HTA computes FFO in accordance with the current standards established by NAREIT. NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures. HTA presents this non-GAAP financial measure because it considers it an important supplemental measure of its operating performance and believes it is frequently used by securities analysts, investors and other interested parties in the evaluation of REITs. Historical cost accounting assumes that the value of real estate assets diminishes ratably over time. Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.
HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on change in fair value of derivative financial instruments; (iii) gain or loss on extinguishment of debt; (iv) noncontrolling income or loss from partnership units included in diluted shares; and (v) other normalizing items, which include items that are unusual and infrequent in nature. HTA presents this non-GAAP financial measure because it allows for the comparison of our operating performance to other REITs and between periods on a consistent basis. HTA's methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs. Normalized FFO should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs. Normalized FFO should be reviewed in connection with other GAAP measurements.
HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) other income or expense; (ii) non-cash compensation expense; (iii) straight-line rent adjustments; (iv) amortization of below and above market leases/leasehold interests and corporate assets; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions. HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of our operating performance. Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of our financial performance, nor is it indicative of cash available to fund cash needs. Normalized FAD should be reviewed in connection with other GAAP measurements.
View original content with multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-third-quarter-2017-earnings-300542158.html
SOURCE Healthcare Trust of America, Inc.
Copyright 2017 PR Newswire
1 Year Healthcare Trust of Amer... Chart |
1 Month Healthcare Trust of Amer... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions